findmyKOL
Clinical trialNCT00622336CompletedPhase 3Interventional

A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma

SponsorCelgeneEnrollment330Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Russia
  • Republican Clinical Hospital #1

    Izhevsk, Russia

  • Nizhny Novgorod Clinical Hospital N.A.Semashko

    Nizhny Novgorod, Russia

  • Novosibirsk State Regional Clinical

    Novosibirsk, Russia

  • Samara Regional Clinical Hospital

    Samara, Russia

Ukraine
  • Kharkov Postgraduate Medical Academy Kharkov Regional Clinical

    Kharkiv, Ukraine

  • Institute of Hematology and Transfusiology of the Uams Department of Blood Diseases

    Kiev, Ukraine

  • Odessa Regional Clinical Hospital

    Odesa, Ukraine

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Apr 2003
Primary completion
25 Nov 2013
Completion
25 Nov 2013
Last update posted
20 Nov 2019
Registered enrollment
330
Registry id
NCT00622336

Cross-registrations

EU-CTR / CTIS (EudraCT)2004-002102-30

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.